RE: Some real big trades20 Jan 2026 15:40
A significant re-rating is expected to occur in Q1 2026, as the company anticipates receiving all final regulatory approvals from South Africa and the UK during this quarter.
The announcement of licensing and acquisition completion acts as a primary "de-risking" event, which typically triggers a rapid market correction toward analyst targets.
Expected Re-rating Catalysts in Q1 2026
Immediate Funding Unlock: Upon receipt of South African regulatory approvals, a strategic investor has the right to immediately inject a further £6.5 million in convertible loan funding within 10 days.
Acquisition Completion: Approval allows the company to finalize the purchase of the Beisa Mine from Sibanye-Stillwater, officially moving multi-billion dollar resources onto their balance sheet.
Analyst Price Targets: Market commentators and analysts (such as Shore Capital) have previously set a Net Asset Value (NAV) target of 14p per share, which represents a potential 1,750% increase from the current 0.80p level.
Recent Market Reaction (January 19-20, 2026)
The market has already shown high sensitivity to positive news. On January 19, 2026, shares jumped approximately 6.5% to 16% in early trading following news of an initial £2.5 million strategic investment at a 0.90p premium.
Post-Licensing Timeline
Once the licenses are secured in Q1 2026, the company will immediately transition into a four-phase implementation assessment:
Months 0–3: Site re-establishment and workforce recruitment.
Months 3–9: Shaft equipment upgrades and gold plant recommissioning.
Target H1 2027: First uranium sales and full production ramp-up.
Because the market often "buys the rumor and sells the news," the most aggressive re-rating typically happens the moment the regulatory barrier is removed, rather than waiting for the first day of production.
Neo